SLU-PP-332

Mechanism of Action

SLU-PP-332 is believed to influence cellular energy metabolism primarily by stimulating mitochondrial activity. It enhances mitochondrial energy production processes and fat oxidation via metabolic and mitochondrial pathways rather than acting as a central nervous system stimulant. This can improve metabolic efficiency and cellular energy utilization, potentially increasing endurance and fat metabolism through modulation of mitochondrial bioenergetics.

Reported Research Benefits

• Used in research to investigate metabolism, mitochondrial function, energy expenditure, and fat oxidation. It is explored for its potential to enhance metabolic efficiency, support fat burning without traditional stimulants, and improve endurance and energy homeostasis.

Dosing Protocol & Reconstitution

Research Notes

Preclinical studies suggest SLU-PP-332 enhances mitochondrial energy production and fat oxidation. It is popular in experimental settings focused on metabolic health and body composition optimization. Batch testing confirms identity and purity, supporting reliable research outcomes.

Research Summary

SLU-PP-332 is a synthetic agonist of estrogen-related receptors (ERRα, ERRβ, ERRγ), nuclear receptors that regulate mitochondrial biogenesis and oxidative metabolism. In rodent studies, it increases endurance by up to 70% without exercise by activating slow-twitch muscle fiber programs and enhancing fatty acid oxidation — a 'super exercise mimetic.' It also shows potential in heart failure models by improving cardiac efficiency.

Side Effects & Safety

Preclinical compound with no published human safety data. Animal studies showed no acute toxicity. ERR modulation could affect estrogen-related signaling pathways; endocrine effects require evaluation. Intended for research use only.

Stability & Storage

Refer to research notes

Molecular Data

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=SLU-PP-332+ERR+exercise+mimetic